Suppression of Autoimmune Retinal Inflammation by an Antiangiogenic Drug

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Yoshimura, Takeru ^a   Benny, Ofra ^a   Bazinet, Lauren ^a   D'Amato, Robert J ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 6; LODAMIN; METHIONYL AMINOPEPTIDASE 2; RETINOL BINDING PROTEIN; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; AUTOIMMUNE UVEITIS; CD4+ T LYMPHOCYTE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; FEMALE; HISTOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; INTERNALIZATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE MIGRATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL;

ADMINISTRATION, ORAL; ANGIOGENESIS INHIBITORS; ANIMALS; ANTIGENS, CD3; AUTOIMMUNE DISEASES; CELL DIFFERENTIATION; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; INFLAMMATION MEDIATORS; LYMPH NODES; LYMPHOCYTE ACTIVATION; MICE; MODELS, BIOLOGICAL; POLYESTERS; RETINITIS; SESQUITERPENES; T-LYMPHOCYTE SUBSETS; TH1 CELLS; TH17 CELLS; UVEITIS;

EID: 84878965911     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066219     Document Type: Article

References (28)

1. Horai R, Caspi RR, (2011) Cytokines in autoimmune uveitis. J Interferon Cytokine Res 31: 733-744.
2. de Smet MD, Taylor SR, Bodaghi B, Miserocchi E, Murray PI, et al. (2011) Understanding uveitis: the impact of research on visual outcomes. Prog Retin Eye Res 30: 452-470.
3. Bettelli E, Oukka M, Kuchroo VK, (2007) T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol 8: 345-350.
4. Amadi-Obi A, Yu CR, Liu X, Mahdi RM, Clarke GL, et al. (2007) TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat Med 13: 711-718.
5. Chi W, Zhu X, Yang P, Liu X, Lin X, et al. (2008) Upregulated IL-23 and IL-17 in Behcet patients with active uveitis. Invest Ophthalmol Vis Sci 49: 3058-3064.
6. McEwen BS, Biron CA, Brunson KW, Bulloch K, Chambers WH, et al. (1997) The role of adrenocorticoids as modulators of immune function in health and disease: neural, endocrine and immune interactions. Brain Res Brain Res Rev 23: 79-133.
7. Smolen JS, Emery P, (2011) Infliximab: 12 years of experience. Arthritis Res Ther 13Suppl 1: S2.
8. Ogata A, Tanaka T, (2012) Tocilizumab for the treatment of rheumatoid arthritis and other systemic autoimmune diseases: current perspectives and future directions. Int J Rheumatol 2012: 946048.
9. Hansel TT, Kropshofer H, Singer T, Mitchell JA, George AJ, (2010) The safety and side effects of monoclonal antibodies. Nat Rev Drug Discov 9: 325-338.
10. Benny O, Fainaru O, Adini A, Cassiola F, Bazinet L, et al. (2008) An orally delivered small-molecule formulation with antiangiogenic and anticancer activity. Nat Biotechnol 26: 799-807.
11. Griffith EC, Su Z, Niwayama S, Ramsay CA, Chang YH, et al. (1998) Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2. Proc Natl Acad Sci U S A 95: 15183-15188.
12. Zhang Y, Griffith E, Sage J, Jacks T, Liu J, (2000) Cell cycle inhibition by the anti-angiogenic agent TNP-470 is mediated by p53 and p21WAF1/CIP1. Proc Natl Acad Sci U S A 97: 6427-6432.
13. Mauriz J, Gonzalez P, Duran M, Molpeceres V, Culebras J, et al. (2007) Cell-cycle inhibition by TNP-470 in an in vivo model of hepatocarcinoma is mediated by a p53 and p21WAF1/CIP1 mechanism. Transl Res 149: 46-53.
14. Damsker JM, Hansen AM, Caspi RR, (2010) Th1 and Th17 cells: adversaries and collaborators. Ann N Y Acad Sci 1183: 211-221.
15. Caspi RR (2003) Experimental autoimmune uveoretinitis in the rat and mouse. Curr Protoc Immunol Chapter 15: Unit 15 16.
16. Caspi RR, Silver PB, Luger D, Tang J, Cortes LM, et al. (2008) Mouse models of experimental autoimmune uveitis. Ophthalmic Res 40: 169-174.
17. Benny O, Nakai K, Yoshimura T, Bazinet L, Akula JD, et al. (2010) Broad spectrum antiangiogenic treatment for ocular neovascular diseases. PLoS One 5.
18. Weninger W, Carlsen HS, Goodarzi M, Moazed F, Crowley MA, et al. (2003) Naive T cell recruitment to nonlymphoid tissues: a role for endothelium-expressed CC chemokine ligand 21 in autoimmune disease and lymphoid neogenesis. J Immunol 170: 4638-4648.
19. Mora JR, von Andrian UH, (2006) T-cell homing specificity and plasticity: new concepts and future challenges. Trends Immunol 27: 235-243.
20. Venturi GM, Tu L, Kadono T, Khan AI, Fujimoto Y, et al. (2003) Leukocyte migration is regulated by L-selectin endoproteolytic release. Immunity 19: 713-724.
21. Chao CC, Jensen R, Dailey MO, (1997) Mechanisms of L-selectin regulation by activated T cells. J Immunol 159: 1686-1694.
22. Peacock DJ, Banquerigo ML, Brahn E, (1992) Angiogenesis inhibition suppresses collagen arthritis. J Exp Med 175: 1135-1138.
23. Oliver SJ, Banquerigo ML, Brahn E, (1994) Suppression of collagen-induced arthritis using an angiogenesis inhibitor, AGM-1470, and a microtubule stabilizer, taxol. Cell Immunol 157: 291-299.
24. Brahn E, Schoettler N, Lee S, Banquerigo ML, (2009) Involution of collagen-induced arthritis with an angiogenesis inhibitor, PPI-2458. J Pharmacol Exp Ther 329: 615-624.
25. Clavel G, Bessis N, Boissier MC, (2003) Recent data on the role for angiogenesis in rheumatoid arthritis. Joint Bone Spine 70: 321-326.
26. Avichezer D, Silver PB, Chan CC, Wiggert B, Caspi RR, (2000) Identification of a new epitope of human IRBP that induces autoimmune uveoretinitis in mice of the H-2b haplotype. Invest Ophthalmol Vis Sci 41: 127-131.
27. Thurau SR, Chan CC, Nussenblatt RB, Caspi RR, (1997) Oral tolerance in a murine model of relapsing experimental autoimmune uveoretinitis (EAU): induction of protective tolerance in primed animals. Clin Exp Immunol 109: 370-376.
28. Benita Y, Cao Z, Giallourakis C, Li C, Gardet A, et al. (2010) Gene enrichment profiles reveal T-cell development, differentiation, and lineage-specific transcription factors including ZBTB25 as a novel NF-AT repressor. Blood 115: 5376-5384.